Staff Publishing

Recent Journal Publications

1. Shapiro AD. Hemophilia B (Factor IX Deficiency). In Disorders of Hemostasis & Thrombosis, 2nd edition. Goodnight and Hathaway; McGraw-Hill. 2001.

2. Shapiro AD. Coagulation factor concentrates. In Disorders of Hemostasis & Thrombosis, 2nd edition. Goodnight and Hathaway; McGraw-Hill. 2001.

3. Bjorkman S, Shapiro AD, Berntorp E. Pharmacokinetics of recombinant factor IX in relation to age of the patient: dosing in prophylaxis. Haemophilia. 7(2):133-139, 2001.

4. Shapiro AD. Inhibitor treatment: state of the art. Seminars in Hematology. 38;4(12): 26-34, 2001.

5. Shapiro AD, Donfield SM, Lynn HS, Cool VA, Stehbens JA, Hunsberger SL, Tonetta S, Gomperts ED and the Academic Achievement in Children with Hemophilia Study Group. Defining the impact of hemophilia: The Academic Achievement in Children with Hemophilia Study. Pediatrics. 108(6): E105, 2001.

6. Ewenstein BM, Joist JH, Shapiro AD, Hofstra TC, Leissinger CA, Seremetis SV, Broder M, Mueller-Velten G, Schwartz BA. Pharmacokinetic analysis of plasma-derived and recombinant fIX concentrates in previously treated patients with moderate or severe hemophilia B. Transfusion. 42(2):190-7, 2002.

7. Evatt BL, Farrugia A, Shapiro AD, Wilde JT. Haemophilia 2002: Emerging risks of treatment. Haemophilia. 8(3): 221-9, 2002.

8. Parameswaren R, Shapiro AD, Cox Gill J, Kessler CM. Dose effect and efficacy of recombinant factor VIIa (rFVIIA) in the treatment of hemophilia patients with inhibitors: analysis from the Hemophilia Research Society (HRS) registry. Blood. 100(11): 22a; 69, 2002.

9. Tarantino MD, Lail A, Donfield SM, Lynn H, Peddle L, Hunsberger S, Shapiro AD. Surveillance of infectious complications associated with central venous access devices in children with haemohilia. Haemophilia. 9(5): 588- 592, 2003.

10. Mathew P, Greist A, Maahs JA, Lichtenberg EC, Shapiro AD. Type 2B vWD: the varied clinical manifestations in two kindreds. Haemophilia. 9(1):137-44, 2003.

11. Shapiro AD. A global view on prophylaxis: possibilities & consequences. Haemophilia. 9(1):10-17, 2003.

12. Shapiro AD. Utilization/cost pharmacokinetic modeling for prophylaxis in factor IX deficiency: rFIX versus pdFIX. International Monitor on Hemophilia. 11(2), 2003.

13. Shapiro AD. Why is primary prophylaxis underutilized in the United States? Haemophilia. 9(6): 670-672, 2003.

14. Brown D, Shapiro A, Schuster V, Mets M. Treatment of ligneous conjunctivitis with fresh frozen plasma. Blood. 102(11): 1108a;309, 2003.

15. Ewenstein B, Collins P, Shapiro A, Tarantino M, Blanchette V, [Baxter Authors], and the rAHF-PFM Study Group. Global evaluation of Advate rAHF-PFM, an advanced category antihemophilic factor prepared using a plasma/albumin-free method. Blood. 102(11): 171a;52, 2003.

16. Saxena K, Gross T, Zhou B, Kraut E, Shapiro A, Hord J, Ruymann F, Yu CY. Immunogenetics of hemophilia inhibitors: a multicenter study. Blood. 102(11): 2961a;800, 2003.

17. Parameswaran R, Shapiro AD. The use of recombinant factor VIIa in gastrointestinal bleeding. Transfusion Alternatives in Transfusion Medicine. 5(5): 23-30, 2003.

18. Greist A. Guest Editor. An update in prothrombotic states and stroke. Seminars in Cerebrovascular Diseases and Stroke. 2(2), 2002.

19. Greist A. Prothrombotic states in HIV disease and stroke complications. Seminars in Cerebrovascular Diseases and Stroke. 2(2):159-169, 2002.

20. Bales J, Greist A. Combined prothrombotic risk factors in a case of cardioembolic stroke. Seminars in Cerebrovascular Diseases and Stroke. 2(2): 172-175, 2002.

21. Greist A. The role of blood component removal in essential and reactive thrombocytosis. Therapeutic Apheresis. 2; 6(1): 36-44, 2002.

Other Publishing Activities

Author of a CME-accredited CD-ROM. A Physician's Interactive Primer on Hemophilia and Other Bleeding Disorders. November, 2002.

Other Staff Publications

Ellett ML, Maahs JA, Forsee S. Prevalence of feeding tube placement errors and associated risk factors in children. The American Journal of Maternal Child Nursing. 23(5): 234-39, 1998.

Mulherin, T. "For comprehensive treatment centers, the heart of the matter is patient care." HemAware. April 1999.

Mulherin, T. "Online postcards from camp: a new way to write home." HemAware. May/June, 2000.

Mulherin, T. "Innovative education: IHTC uses multimedia approach" HemAware. February, 2001.

Mulherin, T. "Art and hemophilia: a therapeutic connection?" HemAware. September/October, 2001.